Sandoz, a division of the Novartis group, is a global leader in the field of generic pharmaceuticals and has a portfolio of more than 840 molecules in over 5,000 Stock Keeping Units in various concentrations, formats and delivery systems. Sandoz products are sold in more than 110 countries worldwide. Sandoz Canada Inc. is one of the very few sites amongst the Sandoz group that combines product development, manufacturing, commercialization and distribution, specializing in the development and manufacture of sterile injectables and ophthalmics. The company currently employs over 700 employees.
Michel Robidoux, President & Chief Executive Officer
Address:
145 Jules-Léger Street
Boucherville, QC J4B 7K8
Canada
Telephone number:
450-641-4903
Ext.
2598
Fax number:
450-641-8615
Sandoz Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
This is the responsible officer name as provided in the most recent registration for the corporation or organization.
Name | From | To |
---|---|---|
Sandoz Canada Inc. | 2024-03-12 | current |
Sandoz Canada Inc. | 2009-01-01 | 2024-03-12 |
Responsible Officer Name | From (YYYY-MM-DD) | To (YYYY-MM-DD) |
---|---|---|
Michel Robidoux | 2010-04-01 | Current |
Pierre Fréchette | 2009-01-01 | 2010-04-01 |
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.
Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.
Results below are sorted by posted date, beginning with the most recent.
Position | Period Held | Last Date Designated Public Office Held |
---|---|---|
Manager, Oral Products Unit
Health Canada, Pharmaceutical Quality |
1996 to March 1999 | Not a designated office |
A/Manager
Health Canada, DIN products Unit |
1994 to 1994 | Not a designated office |
A/Head, CMC Section
Health Canada, Biopharmaceutical Evaluation |
1994 to 1994 | Not a designated office |
Senior Evaluator
Health Canada, Sterile Products and Oral Product Divisions |
1991 to 1996 | Not a designated office |
Pharmaceutical evaluation officer
Health Canada, Pharmaceutical Quality |
1987 to 1991 | Not a designated office |